Phillips K, Bentley MC, Abrar M, Howard DA, Cook J. Low level saliva cotinine determination and its application as a biomarker for environmental tobacco smoke exposure. Hum Exp Toxicol 1999; 18:291–6. [Crossref]
Steenland K, Sieber K, Etzel RA, Pechacek T, Maurer K. Exposure to environmental tobacco smoke and risk factors for heart disease among never smokers in the third national health and nutrition examination survey. Am J Epidemiol 1998; 147:932–9. [Crossref]
US Environmental Protection Agency. Respiratory health effects of passive smoking: lung cancer and other disorders. EPA/600/6-90/006F. Office of Research and Devel-opment, Office of Health and Environmental Assessment, Washington, DC, 1992.
US Department of Health and Human Services. The health consequences of involuntary smoking. A report of the Surgeon General. DHHS publication no. (PHS) 87-8398. US DHHS, Public Health Service, Office of the Assistant Secretary for Health, Office of Smoking and Health, Washington, DC, 1986.
Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health 1984; 38:335–9. [Crossref]
Jaakkola MS, Jaakkola JJ. Assessment of exposure to environmental tobacco smoke. Eur Respir J 1997; 10:2384–97. [Crossref]
Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 1998; 71:162–8. [Crossref]
Watts RR, Langone JJ, Knight GJ, Lewtas J. Cotinine analytical workshop report: consideration of analytical methods for determining cotinine in human body fluids as a measure of passive exposure to tobacco smoke. Environ Health Perspect 1990; 84:173–82.
Forastiere F, Mallone S, Lo Presti E, Baldacci S, Pistelli F, Simoni M, et al. Characteristics of non-smoking women exposed to spouses who smoke. Epidemiologic study on environment and health in women from four Italian areas (SEASD). Environ Health Persp 2000; 108:1171–7. [Crossref]
Farchi S, Forastiere F, Pistelli R, Baldacci S, Simoni M, Perucci CA, et al. SEASD Group. Exposure to environmental tobacco smoke is associated with lower plasma beta-carotene levels among nonsmoking women married to a smoker. Cancer Epidemiol Biomarkers Prev 2001; 10:907–9.
Bigazzi F, Pino BD, Forastiere F, Pistelli R, Rossi G, Simoni M, et al. HDL and clinical and biochemical correlates in Italian non-smoker women. Clin Chem Lab Med 2004; 42:1408–16. [Crossref]
Baldacci S, Carrozzi L, Viegi G, Giuntini C. Assessment of respiratory effect of air pollution: study design on general population sample. J Environ Pathol Toxicol Oncol 1997; 16:128–34.
Viegi G, Pedreschi M, Baldacci S, Chiaffi L, Pistelli F, Modena P, et al. Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int J Tuberc Lung Dis 1999; 3:1034–42.
SIDRIA Collaborative Group. Asthma and respiratory symptoms in 6–7 yr old Italian children: gender, latitude, urbanisation and socio-economic factors. Eur Respir J 1997;10:1780–6.
Agabiti N, Mallone S, Forastiere F, Corbo GM, Ferro S, Renzoni E, et al. The impact of parental smoking on asthma and wheezing. SIDRIA Collaborative Group. Studi Italiani sui Disturbi Respiratori nell'Infanzia e l'Ambiente. Epidemiology 1999; 10:692–8. [Crossref]
ISAAC (The International Study of Asthma and Allergies in Childhood). World-wide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225–32.
Davis RA. The determination of nicotine and cotinine in plasma. J Chromatogr Sci 1986; 24:134–41. [Crossref]
Van Vunakis H, Gijka HB, Langone JJ. Radioimmunoassay for nicotine and cotinine. In: Seifer B, Van de Wiel HJ, Dodet B, O'Neill IK, editors. Environmental carcinogens: methods of analysis and exposure measurements. Lyon, France: IARC Scientific Publications, 1993;109:293–9.
Matt GE, Wahlgren DR, Hovell MF, Zakarian JM, Bernert JT, Meltzer SB, et al. Measuring environmental tobacco smoke exposure in infants and young children through urine cotinine and memory-based parental reports: empirical findings and discussion. Tob Control 1999; 8:282–9. [Crossref]
Jatlow P, McKee S, O'Malley SS. Correction of urine cotinine concentrations for creatinine excretion: is it useful? Clin Chem 2003; 49:1932–4. [Crossref]
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29–36. [Crossref]
Wagenknecht LE, Manolio TA, Sidney S, Burke GL, Haley NJ. Environmental tobacco smoke exposure as determined by cotinine in black and white young adults: the CARDIA Study. Environ Res 1993; 63:39–46. [Crossref]
Riboli E, Haley NJ, Tredaniel J, Saracci R, Preston-Martin S, Trichopoulos D. Misclassification of smoking status among women in relation to exposure to environmental tobacco smoke. Eur Respir J 1995; 8:285–90. [Crossref]
Pierce JP, Dwyer T, DiGiusto E, Carpernter T, Hannam C, Amin A, et al. Cotinine validation of self-reported smoking in commercially run community surveys. J Chronic Dis 1987; 40:689–95. [Crossref]
Jenkins RA, Counts RW. Personal exposure to environmental tobacco smoke: salivary cotinine, airborne nicotine, and nonsmoker misclassification. J Expo Anal Environ Epidemiol 1999; 9:352–63. [Crossref]
Bramer SL, Kallungal BA. Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 2003; 8:187–203. [Crossref]
Pokorski TL, Chen WW, Bertholf RL. Use of urine cotinine to validate smoking self-reports in U.S. Navy recruits. Addict Behav 1994; 19:451–4. [Crossref]
Williams CL, Eng A, Botvin GJ, Hill P, Wynder EL. Validation of students' self-reported cigarette smoking status with plasma cotinine levels. Am J Public Health 1979; 69:1272–4. [Crossref]
Haley NJ, Colosimo SG, Axelrad CM, Harris R, Sepkovic DW. Biochemical validation of self-reported exposure to environmental tobacco smoke. Environ Res 1989; 49:127–35. [Crossref]
Kemmeren JM, van Poppel G, Verhoef P, Jarvis MJ. Plasma cotinine: stability in smokers and validation of self-reported smoke exposure in nonsmokers. Environ Res 1994; 66:235–43. [Crossref]
Bentley MC, Abrar M, Kelk M, Cook J, Phillips K. Validation of an assay for the determination of cotinine and 3-hydroxycotinine in human saliva using automated solid-phase extraction and liquid chromatography with tandem mass spectrometric detection. J Chromatogr B Biomed Sci Appl 1999; 723:185–94.
Emmons KM, Abrams DB, Marshall R, Marcus BH, Kane M, Novotny TE, et al. An evaluation of the relationship between self-report and biochemical measures of ETS exposure. Prev Med 1994; 23:35–9. [Crossref]
Binnie V, McHugh S, Macpherson L, Borland B, Moir K, Malik K. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine. Oral Dis 2004; 10:287–93. [Crossref]
Vine MF, Hulka BS, Margolin BH, Truong YK, Hu PC, Schramm MM, et al. Cotinine concentrations in semen, urine, and blood of smokers and nonsmokers. Am J Public Health 1993; 83:1335–8. [Crossref]
Delfino RJ, Emst P, Jaakkola MS, Solomon S, Becklake MR. Questionnaire assessments of recent exposure to ETS in relation to salivary cotinine. Eur Respir J 1993; 6:1104–8.
Wall MA, Johnson J, Jacob P, Benowitz NL. Cotinine in serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health 1988; 78:699–701. [Crossref]
Williamson IJ, Martin CJ, McGill G, Monie RD, Fennerty AG. Damp housing and asthma: a case-control study. Thorax 1997; 52:229–34. [Crossref]
Norbäck D, Björnsson E, Janson C, Palmgren U, Boman G. Current asthma and biochemical signs of inflammation in relation to building dampness in dwellings. Int J Tuberc Lung Dis 1999; 3:368–76.
Willers S, Axmon A, Feyerabend C, Nielsen J, Skarping G, Skerfving S. Assessment of environmental tobacco smoke exposure in children with asthmatic symptoms by questionnaire and cotinine concentration in plasma, saliva, and urine. J Clin Epidemiol 2000; 53:715–21. [Crossref]
Bernert JT Jr, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, et al. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997; 43:2281–91. [PubMed]
Vineis P, Airoldi L, Veglia F, Olgiati L, Pastorelli R, Autrup H, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. Br Med J 2005; 330:277–81. [Crossref]
Jarvis MJ, Russel MA, Benowitz NL, Feyerabend C. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health 1988; 78:696–8. [Crossref]
Curvall M, Elwin CE, Kazemi-Vala E, Warholm C, Enzell CR. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 1990; 38:281–7. [Crossref]
Dempsey D, Jacob P, Benowitz NL. Nicotine metabolism and elimination kinetics in newborn. Clin Pharmacol Ther 2000; 67:458–65. [Crossref]
Haley NJ, Sepkovic DW, Hoffmann D. Elimination of cotinine from body fluids: disposition in smokers and non-smokers. Am J Public Health 1989; 79:1046–8. [Crossref]